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BACKGROUND: Iron deficiency is difficult to diagnose in critically ill patients, but
may be frequent and may impair recovery. Measurement of hepcidin could help in
the diagnosis of iron deficiency. We aim to assess if iron deficiency diagnosed using
hepcidin is associated with poorer outcome one year after an intensive care unit stay.
METHODS: We used the prospective FROG-ICU, multicentre (n = 28 ICUs),
observational cohort study of critically ill survivors followed up one year after
intensive care unit discharge. Iron deficiency was defined as hepcidin < 20 ng/l,
ferritin < 100 ng/l or soluble transferrin receptor (sTfR)/log(ferritin) > 0.8, measured
in blood drawn at intensive care unit discharge. Main outcomes were one-year all-
cause mortality and poor quality of life (defined as a Short Form 36 (SF-36) score
below the median).
RESULTS: Among the 2087 patients in the FROG-ICU cohort, 1570 were discharged
alive and 1161 had a blood sample available at intensive care unit discharge and
were included in the analysis. Using hepcidin, 429 (37%) patients had iron deficiency,
compared to 72 (6%) using ferritin alone and 151 (13%) using the sTfR/log(ferritin)
ratio. Iron deficiency diagnosed according to low hepcidin was an independent
predictor of one-year mortality (OR 1.51 (1.10-2.08)) as was high sTfR/log ferritin
ratio (OR = 1.95 (1.27-3.00)), but low ferritin was not. Severe ID, defined as hepcidin
< 10 ng/l, was also an independent predictor of poor one-year physical recovery (1.58
(1.01-2.49)).
CONCLUSIONS: Iron deficiency, diagnosed using hepcidin, is very frequent at
intensive care unit discharge and is associated with increased one-year mortality and
poorer physical recovery. Whether iron treatment may improve these outcomes
remains to be investigated.
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